Psychiatr. praxi. 2015;16(2):49-50

Shared decision making

prof.MUDr.Eva Češková, CSc.
1 CEITEC-MU Brno
2 Psychiatrická klinika FN Brno
3 KIO LF Univerzity Ostrava
4 Oddělení psychiatrie, FN Ostrava

Shared decision making (SDM) is a strategy for including patients in therapeutic decision processes In the somatic medicine the SDM

has been studied and used for several years now. The application of shared decision making to psychiatry is still in the initial stage. The

use of this strategy is expected to improve long-term compliance and outcome. Most studies has been done by German authors which

have proved its feasibility and potential advantages in both acute and long-term treatment in schizophrenia. The SDM represents one

of the important aspects dealing with individualized approach to the patient.

Keywords: shared decision making, treatment, schizophrenia, adherence, outcome

Published: May 18, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Češková E. Shared decision making. Psychiatr. praxi. 2015;16(2):49-50.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Hasan A, Falkai P, Wobrock T, et al. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on theacute treatment of schizophrenia and the management of treatment resistance. World J Biol Psychiatry 2012; 13: 318-378. Go to original source... Go to PubMed...
    2. Hasan A, Falkai P, Wobrock T, et al. WFSBP Task force on Treatment Guidelines for Schizophrenia. Word Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological treatment of Schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects. World J Biol Psychiatry 2013; 14: 2-44. Go to original source... Go to PubMed...
    3. Češková E, Přikryl R, Péč O. Schizofrenie u dospělých. In: Psychiatrie: Doporučené postupy psychiatrické péče IV. Praha: Psychiatrická společnost ČLS JEP, 2014: 44-51.
    4. Hamann J, Leucht S, Kissling W. Shared decision making in psychiatry. Review. Acta Psychiatr Scand 2003; 107: 403-409. Go to original source... Go to PubMed...
    5. Hamann J, Langer B, Winkler V, et al. Shared decision making for inpatients with schizophrenia.Acta Psychiatr Scand 2006; 114: 265-273. Go to original source... Go to PubMed...
    6. Hamann J, Cohen R, Leucht S, Busch R, Kissling W. Shared decision making and long-term outcome in schizophrenia treatment. J Clin Psychiatry 2007; 68: 992-997. Go to original source... Go to PubMed...
    7. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261-276. Go to original source... Go to PubMed...
    8. Horvath AO, Greenberg LS. The development of the Working Alliance Inventory. In: Greenberg LS, Pinsof LS, eds. The Psychotherapeutic Process: A Research Handbook. 1986: p. 529-556.
    9. Thompson K, Kulkarni J, Sergejev WW. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychosis. Schizophr Res 2000; 42: 241-247. Go to original source... Go to PubMed...
    10. Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 1983; 13: 177-183. Go to original source... Go to PubMed...
    11. Hamann J, Mendel R, Cohen R, Heres S, Ziegler M, Bühner M, Kissling W. Psychiatrists' use of shared decision making in the treatment of schizophrenia: patient characteristics and decision topics. Psychiatr Serv 2009; 60: 1107-1112. Go to original source... Go to PubMed...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.